Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals (AVDL) Income Statement


Avadel Pharmaceuticals Income Statement

Last quarter (Q1 2023), Avadel Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Avadel Pharmaceuticals's net income was $-30.78M. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 116.00K$ 116.00K$ 0.00$ 22.33M$ 59.22M$ 103.27M
Cost of Revenue
$ 3.35M$ 3.35M$ 0.00$ 5.74M$ 12.13M$ 17.52M
Gross Profit
$ -3.35M$ -3.35M$ 0.00$ 16.59M$ 47.09M$ 85.75M
Operating Expense
$ 94.89M$ 95.22M$ 85.60M$ 53.25M$ 63.92M$ 146.31M
Operating Income
$ -98.23M$ -98.56M$ -85.60M$ -36.66M$ -16.83M$ -60.55M
Net Non Operating Interest Income Expense
$ -14.43M$ -12.88M$ -9.94M$ -12.99M$ -12.48M$ -10.62M
Other Income Expense
$ -3.05M$ -203.00K$ 2.40M$ 44.57M$ -9.27M$ -42.02M
Pretax Income
$ -112.06M$ -111.44M$ -93.14M$ -5.08M$ -38.58M$ -113.20M
Tax Provision
$ 29.77M$ 26.02M$ -15.82M$ -12.11M$ -5.36M$ -17.89M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -141.82M$ -137.46M$ -77.33M$ 7.03M$ -33.23M$ -95.30M
Basic EPS
$ -2.32$ -2.29$ -1.32$ 0.13$ -0.89$ -2.55
Diluted EPS
$ -2.32$ -2.29$ -1.32$ 0.13$ -0.89$ -2.55
Basic Average Shares
$ 243.22M$ 60.09M$ 58.53M$ 53.00M$ 37.40M$ 37.33M
Diluted Average Shares
$ 243.22M$ 60.09M$ 58.53M$ 54.94M$ 37.40M$ 37.33M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 98.23M$ 98.56M$ 85.60M$ 58.99M$ 76.04M$ 163.82M
Net Income From Continuing And Discontinued Operation
$ -141.82M$ -137.46M$ -77.33M$ 7.03M$ -33.23M$ -95.30M
Normalized Income
$ -81.86M-$ -79.14M$ -23.05M$ -25.24M$ -59.88M
Interest Expense
$ 7.07M-$ 9.94M$ 12.99M$ 12.48M$ 10.62M
$ -97.63M$ -98.56M$ -83.20M$ 7.91M$ -26.10M$ -102.58M
$ -92.03M$ -91.02M$ -82.39M$ 9.60M$ -23.61M$ -95.14M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis